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Mutation rate is a key determinant of the pace as well as outcome of evolution, and variability
in this rate has been shown in different scenarios to play a key role in evolutionary adaptation and
resistance evolution under stress caused by selective pressure. Here we investigate the dynamics
of resistance fixation in a bacterial population with variable mutation rates and show that evolu-
tionary outcomes are most sensitive to mutation rate variations when the population is subject to
environmental and demographic conditions that suppress the evolutionary advantage of high-fitness
subpopulations. By directly mapping a biophysical fitness function to the system-level dynamics of
the population we show that both low and very high, but not intermediate, levels of stress in the
form of an antibiotic result in a disproportionate effect of hypermutation on resistance fixation. We
demonstrate how this behavior is directly tied to the extent of genetic hitchhiking in the system, the
propagation of high-mutation rate cells through association with high-fitness mutations. Our results
indicate a substantial role for mutation rate flexibility in the evolution of antibiotic resistance under
conditions that present a weak advantage over wildtype to resistant cells.
I. INTRODUCTION
The ability to predict the possible trajectories of
a naturally evolving complex living system is key
to describing and anticipating varied ecological and
biomedical phenomena. Such predictability rests on
an understanding of the potential for evolutionary
adaptability of a given system. In asexual popula-
tions a major mechanism responsible for evolutionary
adaptation under environmental stress is the genera-
tion via genetic mutations of phenotypes able to bet-
ter withstand and thrive under the stressor: resistant
populations arising from within a wildtype popula-
tion that may “rescue” the population from the source
of stress by eventually coming to dominate the pop-
ulation. The rate at which such resistant mutations
occur and the balance between these and more delete-
rious mutations are major determinants of whether
the population may survive and adapt to selective
evolutionary pressure [1–5], an environmental stres-
sor that targets strain variants, or phenotypes, non-
uniformly. Although the baseline mutation rate in
bacteria is quite low, at about ∼ 10−3 per genome per
generation [6, 7], high prevalences of mutator strains
in natural bacterial populations and clinical isolates
have been observed in various studies (see [8–11] for
early work and [12] for a survey), and in certain cases
“hypermutability”, an increase in the mutation rate
over the baseline rate, was shown to result in fitness
increases and faster adaptation [5, 13–18] and even
be essential for survival under stress [19] by enabling
genetic hitchhiking on beneficial mutations [5, 20–
22]. Mutation rates can increase under environmen-
tal stress [23–26], and, in particular, hypermutability
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may play a significant role in the rise of antibiotic re-
sistance [27–32].
The potential for adaptability via genetic mutations
is dependent on the interplay between the ensemble
of phenotypes that the system can access via muta-
tions and the rate at which such transitions may oc-
cur within this ensemble. Phenotypes are typically
characterized by some intrinsic measure of evolution-
ary fitness, such as their growth rate or lag phase,
that contributes to evolutionary success, with extrin-
sic conditions, such as the probability of acquisition of
this trait, initial population distribution, or resource
availability, held fixed. Yet evolutionary advantage
is determined by an interplay of these intrinsic and
extrinsic factors, and separating these dependences
while considering only a subset of them is of limited
utility in establishing a global picture of a system’s
evolvability potential as well as specific response to se-
lective pressure. Here, we address both with a view to
investigating the extent to which mutation rate vari-
ability drives adaptation under selective pressure.
The main purpose of this paper is to demonstrate
that evolution under selective pressure – an exter-
nal stressor that induces a fitness gradient in a given
population – may not be uniformly sensitive to mu-
tation rate as a function of the selective pressure as
well as additional fitness-determining conditions, and
that this non-uniform behavior should be taken into
account when deciding on an appropriate antibiotic
dosing protocol. In such a situation there is gener-
ally no information available on the mutation rate in
the pathogenic bacterial population, and this rate may
also change in the course of therapy, as noted above.
If dosing can be restricted to ranges for which the
expected evolutionary outcome is less sensitive to the
mutation rate, there will be higher predictive certainty
about the treatment outcome and more reliable strate-
gies can be developed for avoiding antibiotic resistance
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2arising in the course of treatment.
By considering a simple deterministic model of bac-
terial evolution under limited resources, we show that
evolutionary outcome is most sensitive to the muta-
tion rate when there exist phenotypes in the popula-
tion that have a weak advantage – expressed through
either intrinsic traits or extrinsic conditions – over the
phenotype that is initially dominant in the popula-
tion. In Section II we introduce and describe our evo-
lutionary dynamics model; in Section III we define
and motivate our measure of mutation rate sensitivity
and quantify how sensitive the evolutionary success
of a population is to increases in the mutation rate.
We show that the fitness advantage of the resistant
mutant – as given by both intrinsic fitness and extrin-
sic advantage-conferring conditions – is a determining
factor in the extent of this sensitivity. In Section IV,
we focus our analysis on selective evolutionary pres-
sure in the form of a bacterial growth inhibitor (an-
tibiotic) and quantify (i) the dependence of mutation
rate sensitivity to this source of pressure, and (ii) the
extent to which the antibiotic drives the fixation of
hypermutation in the population. We conclude with
a brief discussion of the ramifications of our findings
in Section V.
II. THE MODEL
We consider a system under non-neutral selection
in which up to two distinct phenotypes – defined by
their growth rates gi – may coexist under limited re-
sources. We denote them by wt for wildtype and r
for resistant – designations that are intended to in-
dicate that the r phenotype is more resistant to the
evolutionary pressure considered (e.g. antibiotic, as
in Section IV) under the non-neutral selection expe-
rienced by the population. Each of these phenotypes
may be found with some baseline mutation rate µbl or
with an elevated mutation rate of f×µbl, f > 1. Both
forward and backward mutations are permitted with
equal probability1 pwt,r; transitions between baseline-
mutation phenotype and its elevated-mutation coun-
terpart (of identical growth rate) occur with rate rµ.
In addition, to account for the fitness penalty incurred
due to an increased rate of deleterious mutations at
higher values of f , we assume that either phenotype
1 While resistance can result from the accumulation of a series
of mutations, first-generation mutants – for which the muta-
tion is reversible by a single-point mutation – can already
exhibit discernibly increased resistance [34, 35], with fur-
ther substantial increases in resistance found in some second-
generation mutants, for which the equal probability assump-
tion can be thought of as a “first-order” approximation.
FIG. 1: Schematic indicating the allowed single-step
transitions and their rates between phenotypes.
may experience deleterious mutations with probability
Pdel. Since at non-negligible levels of selective pres-
sure phenotypes whose resistance to the pressure is
weaker than wildtype will have very low growth, we
do not keep track of such low-growth populations ex-
plicitly, but they are implicitly accounted for in our
model as the loss of cells from higher-growth popula-
tions via deleterious mutations. Since we assume that
such loss occurs with uniform probability Pdel, when
the overall genetic mutation rate of a cell is µ, the
rate of deleterious mutations is given by µPdel. Note
that when Pdel is high, increases in µ carry a higher
penalty, implying that for hypermutation to be bene-
ficial and counteract this penalty resistant phenotypes
would have to be significantly advantageous either by
having a much higher growth rate (intrinsic advan-
tage) or, e.g., by occurring with a high probability or
being initially present in relatively high proportions
(extrinsic advantage). Fig. 1 shows a schematic od
this model. We assume deterministic evolution un-
der limited resources, as resources needed for growth
are nearly always constrained in real biological sys-
tems, driving competition between organisms consum-
ing the same resources. The equations governing the
time evolution of this system are given by
x˙k,α(t) =
(
1− xtot(t)
K
)
[gkxk,α(t)
+ µblfαpj,kgjxj,α(t) + rµgkxk,β(t)
−fαµblgk (pk,j + Pdel)− rµgkxk,α(t)]
(2.1)
where j 6= k, j, k ∈ {wt, r}, α 6= β, and a station-
ary population distribution is established when the
total population size xtot =
∑
m,γ xm,γ reaches the
resource capacity K. Note that faster-growing pheno-
types will also produce exponentially more deleterious
mutants as a result of their more frequent divisions,
resulting in the previously noted fitness tradeoff. The
four-dimensional system (Fig. 1) of Eqn. (2.1) is given
explicitly in Appendix A. We consider here the case
where the effect of selective pressure is limited to se-
lecting for hypermutant variants if they are advanta-
3geous but not directly inducing hypermutability (for
work on the latter see e.g., [36–40]). Under this as-
sumption, hypermutation occurs independently of se-
lective pressure and therefore some proportion of the
initial-state population would be expected to already
exhibis elevated mutation rates. We assume in all that
follows that cells with elevated mutation rates con-
stitute 1% of the total initial population (distributed
in proportion to the phenotype distribution) and a
corresponding rate at which hypermutation-conferring
mutations occur of 0.25% of cells per generation (see
Appendix B for an extended discussion of these pa-
rameter choices).
III. SENSITIVITY OF EVOLUTIONARY
SUCCESS TO THE MUTATION RATE
The ability of a population to survive evolutionary
pressure depends on the extent to which resistant phe-
notypes come to dominate it and withstand potential
subsequent applications of the stressor (e.g. in a serial
dilutions experiment). To understand how mutation
rate affects this we consider how the stationary-state
ratio of resistant cells in the population, xr/xtot, at
elevated mutation rates compares with this ratio if all
mutations in the system were restricted to occur at
the baseline rate µbl,
Rr(µ > µbl, ~ρ)
Rr(µbl, ~ρ)
≡ (xr(~ρ)/xtot(~ρ))µ>µbl
(xr(~ρ)/xtot(~ρ))µ=µbl
(3.1)
as a function of the main parameters that arise in our
model, ~ρ = (gr,K, pwt,r, xr(t = 0)/xwt(t = 0)). The
ratio (3.1) represents the extent to which a particular
(elevated) mutation rate is able to drive a successful
evolutionary outcome: a larger proportion of resistant
cells in the stationary-state distribution. We refer to
this as the sensitivity of evolutionary success to the
mutation rate. In Fig. 2a we show how this sensitivity
correlates with our measure of baseline “evolutionary
advantage” of the resistant mutant, Rr(µbl, ~ρ), as dif-
ferent components of ~ρ are varied2. For each of these
model parameters we see that at some fixed muta-
tion rate (show in the plot is a 150-fold increase over
the baseline) sensitivity to the elevation in mutation
rate is highest at low (but positive) levels of the re-
sistant mutant’s evolutionary advantage; it decreases
and eventually becomes negligible (≈ 1) as its evolu-
tionary advantage increases.
2 Since we consider here deterministic dynamics, the ratio
Rr(µ, ~ρ) directly projects ~ρ to the stationary state and should
therefore be viewed as both a final outcome (at stationary-
state) as well as an indicator of the evolutionary advantage
conferred by the system’s intrinsic and extrinsic conditions.
Before proceeding in our analysis, we consider how
the different parameters in ~ρ are in fact indicative of
evolutionary advantage: while it is clear how a higher
growth rate gr, a larger initial proportion xr(t =
0)/xwt(t = 0), and a higher non-deleterious mutation
rate lead to advantageous conditions for the resistant
mutant to increase its proportions in the population,
it is perhaps less obvious why a higher resource capac-
ity produces an advantage specifically for the resistant
mutant given that resource utilization is uniform in
our model among the two phenotypes. The reason for
this is that while the resource capacity appears a pri-
ori to be a non-selective environmental stressor, due
to the exponential growth phase involved in the evolu-
tion of the system (2.1), higher resource capacity puts
off the time of resource saturation, thus compound-
ing the advantage enjoyed by phenotypes with higher
growth rate gk.
By averaging over individual-ρi interpolations
(Fig. 2b) and varying f (Fig. 2c and 2d) we observe
that the largest impact of the presence of elevated mu-
tation rates in the population is under parameter com-
binations that, due to any one or multiple advantage-
determining parameters, result in the resistant pheno-
type having a weak advantage. In these circumstances
the evolutionary advantage of the resistant cells may
be insufficient to establish these populations in high
proportions due to competition for limited resources,
and certain increases in the mutation rate may thus
be critical for adaptation, even at the cost of increased
deleterious mutations. When initial conditions confer
a high advantage on the resistant phenotype, muta-
tion rate increases offer negligible to negative benefit.
The high growth rate of these populations and hence
frequent cell divisions imply that increases in their
mutation rate also drive approximately-exponentially
increases in deleterious mutations, and that when a
strong advantage exists the baseline-mutation pheno-
type will thus rise to fixation faster than its hypermu-
tant counterpart.
As shown in the contour plots of Fig. 2c (Pdel = 0.9)
and 2d (Pdel = 0.6), for any level of resistant mutant
evolutionary advantage, there exists an optimal mu-
tation rate (green curves) yielding the highest propor-
tion of resistant cells. Increasing the mutation rate
up to this rate provides substantial benefit for lower-
advantage mutants, and further increases lead to di-
minishing (albeit more gradually) returns due to the
tradeoff with an increased loss caused by deleterious
mutations. We see (Fig. 2c compared to 2d) that the
level of evolutionary advantage past which there is no
gain from hypermutation is fairly robust to variations
in the rate of deleterious mutations (fµblPdel), but a
lower Pdel extends the range of mutation rates con-
ferring benefit, as in that case there is little loss to
deleterious mutations even at high f .
4(a) (b) (c) (d)
FIG. 2: The sensitivity of evolution success to hypermutation (Rr(f > 1)/Rr(f = 1)) is negatively correlated with the
baseline-mutation rate evolutionary advantage Rr(f = 1) of the resistant mutant and is optimized at a mutation rate increase (f)
that depends on the extent of advantage, diminishing upon further increases in this rate. (a) Rr(f > 1)/Rr(f = 1) versus
Rr(f = 1) curves for individual parameters ~ρ affecting the resistant mutant’s evolutionary advantage at f = 150. (b): averages of
the single-ρi curves in the appropriate ranges put through a low pass filter for smoothness shown at multiple values of f (on a
log-linear scale, for clarity of resolution between different mutation rates). The dashed black line (parity in Rr at baseline and
elevated f) indicates the point of no benefit from hypermutation; initial increases in f yield significant benefit at low-advantage
conditions, which decreases and eventually becomes negligible at high-advantage conditions (Rr(f = 1)→ 1). At very high f
(here f & 700) even low-advantage mutants experience diminishing benefit from hypermutation. (c) and (d):
Rr(f > 1)/Rr(f = 1) contours corresponding to plot (b) in f −Rr(f = 1) space. The green curve shows the optimal (i.e. yielding
highest Rr(f > 1)/Rr(f = 1)) mutation rate increase factor f as a function of Rr(f = 1). The probability of deleterious
mutations was set at Pdel = 0.9 for plots (a)-(c) and at Pdel = 0.6 in plot (d). When held constant, ~ρ parameters were set at
gr/gwt = 3, K/xtot(t = 0) = 102,pwt,r = 0.01, and xr(t = 0) = 0. Wildtype E. coli growth was set at gwt = 0.34 h−1 and
µbl = 2× 10−10 ×Ng , with Ng the size of the E. coli genome.
IV. EFFECT OF SELECTIVE PRESSURE ON
MUTATION RATE SENSITIVITY AND ON
GENETIC HITCHHIKING
In this section we focus on the effect of selective
pressure in the form of an antibiotic that inhibits bac-
terial growth and quantify how the extent of selective
pressure – different antibiotic conentrations – affects
the sensitivity of evolutionary outcome to the muta-
tion rate. The effect of antibiotic concentration on this
quantity arises from the respective dependences of the
phenotypes’ growth rates on this concentration. Mo-
tivated by work [35] on the response of E. coli to vari-
ations in the dosage of trimethoprim, a competitive
inhibitor of dihydrofolate reductase, we assume a hy-
perbolic decay functional dependence for the growth
rate g on the inhibitor concentration [I]
g ([I]) =
g0
1 + [I]/gI
, (4.1)
where g0 is the growth rate in the absence of an in-
hibitor and gI controls the extent to which the popula-
tion may grow in the presence of the inhibitor. In [35]
this functional dependence, with g0 and gI given ex-
plicitly as functions of various protein biophysical and
cellular properties, was shown to agree with experi-
mental measurements for several mutant phenotypes
over a range of [I], and similar methods can in princi-
ple be used to derive g0 and gI from biophysical prin-
ciples for a wider range of biologically-relevant scenar-
ios.
By computing the sensitivity to mutation rate, Eqn.
(3.1), as a function of only the inhibitor with other
parameters held fixed, we show (Fig. 3a) that at low
levels of inhibition, where gI carries only a small fit-
ness advantage and mutant and wildtype growth rates
g([I]) are similar, there is substantial benefit to be
gained from hypermutation. As inhibition is increased
the difference between mutant and wildtype growth
increases, resulting in the resistant mutant easily in-
creasing in proportions without much benefit from hy-
permutation; but at yet higher levels of inhibition the
role of elevated mutation rates in determining adap-
tation once again becomes significant. The behav-
ior of the (intrinsic) selection coefficient gr/gwt − 1
is not revealing in this respect: it monotonically ap-
proaches a constant value at high [I]. However, the
difference between gr and gwt peaks at an interme-
diate value of [I] and decreases at lower and higher
values of [I] (Fig. 4). While the peak does not numer-
ically coincide with the [I] concentrations yielding the
lowest Rr (f > 1) /Rr (f = 1), we note that additional
parameters in ~ρ also affect this ratio.
We next consider the extent to which selective pres-
sure, the antibiotic, affects the extent of hypermuta-
5tion in the population by computing the stationary-
state proportion of hypermutants in the population
when an inhibitor is applied (resistant cells have a
positive evolutionary advantage) relative to when no
inhibition is present (neutral selection),
Rh([I] > 0, ~ρ)
Rh([I] = 0, ~ρ)
≡ (xh(~ρ)/xtot(~ρ))[I]>0
(xh(~ρ)/xtot(~ρ))[I]=0
. (4.2)
as a function of the inhibition (fig. 3a). Fig. 3b
shows contours of Rh ([I] > 0) /Rh ([I] = 0) in a two-
dimensional space of f and [I]. We find (Fig. 3b) that
genetic hitchhiking on resistant mutations as mea-
sured by Rh is most pronounced in a f − [I] phase
space that up to intermediate mutation rate increases
is approximately complementary to that in which hy-
permutation has the most pronounced beneficial ef-
fects. This effect can be explained by noting that at
low inhibition, where the resistant mutant does not
have significant advantage over wildtype, the acqui-
sition of such mutations does not drastically increase
the growth rate of hypermutant cells; on the other
hand, when resistant mutations are highly advanta-
geous (high inhibition), the baseline-mutation resis-
tant mutant rises to fixation largely unaided by hy-
permutation, which under finite resources limits the
growth potential of other subpopulations (resistant
hypermutants). We note that the range of mutation
rates at which we observe hitchhiking to be strongest
is in keeping with experimental observations (see [12]
for a review and [41] for additional recent data) of a
O (101 − 102) increase over baseline in E. coli clinical
isolates (with some data pointing to a nearly O (103)
in certain cases [42]).
(a) (b)
FIG. 3: (a): Hypermutation has strong impact on resistance
fixation at low and at very high levels of inhibition that is
optimized at a mutation rate that depends on the inhibition
level. (b): genetic hitchhiking on resistant mutations is most
pronounced in intermediate levels of inhibition. The black
contour (= 1) indicates no hitchhiking on resistant mutations.
Parameters were set at g0,r = g0,wt = 0.34 h−1, gr,I = 5gwt,I
where gwt,I = 3.6 µg/mL, Pdel = 0.9; and K, pwt,r, and
xr(t = 0) as in Fig. 2.
FIG. 4: While the instrinsic selection coefficient gr/gwt − 1
monotonically increases as a function of inhibition (a), the
difference in growth rates gr − gwt is maximized at
intermediate levels of inhibition (b).
V. DISCUSSION
In obtaining the results presented here we assumed
deterministic dynamics. While mutations typically
arise randomly and can introduce a large degree of
stochasticity into the dynamics, deterministic evolu-
tion can provide important insights into processes
with varying degrees of stochasticity: large popula-
tions are expected to sample a large extent of the
available mutational phase space (with infinite popu-
lations sampling every possible configuration, or geno-
type), and experimental work [33] on evolutionary
pathways in E. coli to drug resistance found similar
mutational trajectories across populations evolved in
parallel. Our deterministic results, moreover, suggest
that stochastic fluctuations in the mutation rate can
have an outsized effect on the stationary state of the
system under a broad range of conditions that sup-
press the evolutionary advantage of emergent resistant
populations. Knowledge of the effects of these condi-
tions in conjunction with a quantitative understand-
ing of how changes in a controllable selective pressure,
such as we modeled here in the case of a growth in-
hibitor, are crucial for forming informed predictions
on how variations in this main driving force of adapta-
tion affect the dynamics of complex, high-dimensional
systems and on how to best minimize the effects of
stochastic fluctuations to establish a desired evolu-
tionary outcome, such as a clinical antibiotic protocol
minimizing the risk of resistance evolution.
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Appendix A: Evolution equations
We consider a population subdivided into wildtype
with growth rate gwt and baseline mutation rate µbl,
a resistant phenotype with this baseline mutation rate
and growth rate gr, and corresponding phenotypes of
equal growth rate but increased mutation rate fµbl,
f > 1. Population levels at time t are given by
xwt,1(t), xr,1(t), xwt,f (t), and xr,f (t), respectively.
Transitions (mutations) between the subpopulations
are permitted in accordance with the schematic Fig. 1.
We assume limited resources set by an environmental
carrying capacity K, so that the subpopulation levels
thus evolve in time according to the equations

x˙wt,1(t) =
(
1− xtot(t)K
)
[(1− µbl (pr,wt + Pdel)− rµ) gwtxwt,1(t) + µblpr,wtgrxdr,1(t) + rµgwtxwt,f (t)]
x˙wt,f (t) =
(
1− xtot(t)K
)
[(1− f × µbl (pr,wt + Pdel)− rµ) gwtxwt,f (t) + f × µblpr,wtgrxr,f (t) + rµgwtxwt,1(t)]
x˙r,1(t) =
(
1− xtot(t)K
)
[(1− µbl (pr,wt + Pdel)− rµ) grxr,1(t) + µblpr,wtgwtxwt,1(t) + rµgrxr,f (t)]
x˙r,f (t) =
(
1− xtot(t)K
)
[(1− f × µbl (pr,wt + Pdel)− rµ) grxr,f (t) + f × µblpr,wtgwtxwt,f (t) + rµgrxr,1(t)]
(A1)
where rµ is the rate of mutation from a baseline-
mutation rate (f = 1) phenotype to a f > 1 phe-
notype (rate at which mutations leading to elevated
mutation rates fµbl occur) and its reverse (assumed
to be equal), pr,wt ≡ pwt→r = pr→wt is the probability
of mutation from wildtype to the resistant phenotype
and backward, Pdel is the probability of mutation to
deleterious phenotypes, xtot = xwt,1 + xwt,1f + xr,1 +
xr,f .
In order to compute the relative advantage or dis-
advantage conferred by hypermutation on the fixation
of drug resistant subpopulations (Eq. 3.1) we numer-
ically compute the ratio of resistant mutants (com-
bined non-hypermutant and hypermutant types) in
the total population at 2 ≤ f ≤ 1000 to the ratio
that would result if no hypermutations were allowed
in the system, i.e. if we set rµ = 0 and consider only
phenotypes xwt,1 and xr,1. When computing these
quantities for a system with an initial distribution of
hypermutants of either phenotype, we assume that
8the rµ = 0 system has a corresponding distribution
in which
xi,rµ=0 (t = 0) = xi,1,rµ 6=0 (t = 0) + xi,f,rµ 6=0 (t = 0) ,
with i representing either wildtype or the resistant
phenotype.
In the figures shown in the main text and in the Sup-
plemental Material µbl was set at 2× 10−10×Ngenome
per generation per cell [6] where Ngenome = 4.64×106
is the number of basepairs in the E. coli genome. In
the results shown in the main text, when the popula-
tion is not purely wildtype at t = 0, the proportion of
hypermutants chosen is assumed to be distributed pro-
portionally amongst the wildtype and resistant popu-
lations.
Appendix B: Rate of acquisition rµ of increased
mutation rate and initial proportion of
hypermutants
To estimate a biologically reasonable rµ we consider
a simple system consisting of a wildtype f = 1 phe-
notype and a wildtype f > 1, both with fitness gwt,
which can mutate into each other with rate rµ:x˙wt,1(t) =
(
1− xwt,1(t)+xwt,f (t)K
)
[(1− rµ) gwtxwt,1(t) + rµgwtxwt,f (t)]
x˙wt,f (t) =
(
1− xwt,1(t)+xwt,f (t)K
)
[(1− rµ) gwtxwt,f (t) + rµgwtxwt,1(t)]
(B1)
The steady-state (stationary distribution) propor-
tion of hypermutants in the total population will be
given by
R =
xwt,f (τ)
xwt,1(τ) + xwt,f (τ)
(B2)
at time τ after resources have been saturated3. Hy-
permutation can be caused by various mechanisms;
studies focused on pathogenic E. coli have found com-
paratively high (> 1%) proportions of mutators in
bacterial isolates (3.6% in [43] and 1.9% in [9]); a sepa-
rate study that looked specifically for MMR deactiva-
tion in E. coli found a much lower proportion (0.24%)
when both commensal and pathogenic E. coli were in-
cluded [8]. A later study [10] found, however, that
when other sources of hypermutation were included
besides MMR, E. coli cells exhibiting increased mu-
tation rates – of up to two orders of magnitude from
the baseline mutation rate – constituted as much as
14% of the total population, most being mild muta-
tors, with both commensal and pathogenic strains in-
cluded in the study. The highest mutation rates were
found to correspond to MMR deficiencies, with lower
increases due to other mechanisms. Note that since rµ
is a neutral-selection rate, studies of mutator propor-
tions that were conducted under conditions of adap-
tive evolution will likely overestimate this parameter
and we therefore restrict our data to studies of natu-
3 Since our goal in the analysis of this section is to obtain a
first-order estimate for rµ that is independent of the pre-
cise mutation rate we omit the potential effect of deleterious
mutations here via Pdel, as the magnitude of this effect will
depend on the actual mutation frequency fµbl of the hyper-
mutators.
ral isolates, noting that even in those cases adaptive
evolution in the recent past may have taken place.
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FIG. 5: Computed values of rµ from the system (B1) for
different expected steady-state proportions of resistant
cells as the availability of resources is varied. Across a
wide range of carrying capacities rµ only varies from
∼ 0.5% to ∼ 1.5%. Plots in the main text employ
rµ = 0.25%, corresponding to an initial hypermutant
population of 1% of the total population.
We compute which rµ values yield the stationary
distribution ratio (B2) for different carrying capaci-
ties by taking gwt as in the main text to be 0.34 h−1
under no inhibition. The results for different values of
R are shown in Fig. 5. Since we consider a uniform dis-
tribution4 of mutation rate increase factors f and the
14% figure is heavily tipped towards mild mutators,
4 A non-uniform distribution can be incorporated by multiply-
ing rµ by a probability distribution that depends on f - as
this adds additional degrees of freedom to the model we avoid
doing so here.
9using this figure will likely overestimate the mutation
rate rµ in our model for higher values of f . For the
purpose of the plots in the main text we set on the
lower end, at rµ = 0.25% and an initial proportion of
1% hypermutating cells in the population.
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S1 Results for a spectrum of rµ and Pdel
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Figure S1: Sample bimodal distributions of fitness effects shown in terms of the probability of mutation as a
function of the selection coefficient, s ≡ gmut/gwt− 1, with the green and light red regions indicating mutations
with beneficial and mildly deleterious effects, respectively. The darker red region indicates strongly deleterious
and lethal mutations.
Experimental findings on distributions of fitness effects (DFEs) across a variety of organisms and conditions
point to a probability peak around neutral (wildtype) fitness that is skewed toward mildly to somewhat delete-
rious mutations (Fig S1). The proportion of lethal or near-lethal mutations varies greatly in the literature and
exhibits a dependence on both the organism studied and the experimental conditions: earlier studies (e.g. [1])
found a bimodal distribution to be typical, whereas a recent study has observed far fewer lethal mutations in E.
coli, consituting only about 1% of all mutations recorded [2]. In view of these differing data and the possibility
that ambient conditions may affect the DFE, it is important to establish the extent to which our conclusions in
this study are robust against variations in the balance between the rate of deleterious, neutral, and beneficial
mutations. The probability of beneficial mutations was one of the main indicators of selective advantage that
we explored in the main text as a component of advantage-conferring conditions ~ρ; here we consider changes in
Pdel – the probability assigned to strongly deleterious or lethal mutations in our model.
Figs. S2 and S3 show plots corresponding to Fig. 2(c)-(d) and Fig. 3 in the main text for different combi-
nations of Pdel and rµ with corresponding choices of initial hypermutant proportion, xh,0/xtot,0 based on the
analysis in the previous section. We see from Fig. S2 that the effects of increasing Pdel, i.e. altering the balance
of beneficial to deleterious mutations to result in a higher rate of deleterious mutations, are (1) to shift the opti-
mal mutation rate (i.e. to more strongly constrain the range of mutation rate increases f that benefit resistance
fixation) to lower values for a given level of baseline-rate advantage (Rr(f = 1)); and (2) to increase the overall
impact of hypermutation (Rr(f > 1)/Rr(f = 1)) for a given level of baseline-rate advantage. Importantly,
however, the level of advantage at which hypermutation no longer plays a role does not significantly change over
a large range of variations in Pdel, indicating that our main results about the role of hypermutation as a function
of evolutionary advantage are qualitatively robust against changes in the distribution of fitness effects. We see
that changes in rµ and xh,0/xtot,0 carry a significant quantitative impact on Rr(f > 1)/Rr(f = 1) and that
higher values of rµ and xh,0/xtot,0 result in little to no loss in Rr(f > 1)/Rr(f = 1) even at very high mutation
rates. The effects due to changes in Pdel and (rµ, xh,0/xtot,0) carry over to the behavior of Rr(f > 1)/Rr(f = 1)
and Rh([I] > 0)/Rh([I] = 0) as shown in Fig. S3.
1
Figure S2: Contour plots of Rr(f > 1)/Rr(f = 1) (Eqn. (3.1) in the main text) in f -Rr(f = 1) space correspond-
ing to those shown in Fig. 2(c)-(d) in the main text (with parameters noted there) at different combinations
of (rµ, Pdel) and the approximate2 proportion of initial-state hypermutants (xh,0/xtot,0) corresponding to this
choice of rµ based on the analysis plotted in Fig. 5 in the Appendix.
2 Since we consider a range of K values in calculating Rr(f > 1)/Rr(f = 1), the choice of xh,0/xtot,0 corresponding to
rµ is approximate.
2
Figure S3: Side-by-side contour plots for the effects of inhibition on resistance fixation (Rr(f > 1)/Rr(f = 1))
and hypermutation fixation (Rh([I] > 0)/Rh([I] = 0)) in f -[I] space corresponding to those shown in Fig. 3(a)-
(b) in the main text (with parameters noted there) at different combinations of (rµ, Pdel) and the approximate
proportion of initial-state hypermutants (xh,0/xtot,0) corresponding to this choice of rµ based on the analysis
plotted in Fig. 5 in the Appendix. The location of Rh([I] > 0) = Rh([I] = 0) is shown in the black curve,
indicates the point of no hitchhking of hypermutants on resistant mutations.
3
S2 Subpopulation fixation dynamics
Shown below are the frequencies of each of the four subpopulations in the model as a function of time at different
mutation rates. In the main text, proportions were calculated from the stationary population distribution.
Figure S4: Frequencies (proportions in total population) over time of each of the four subpopulations in the
model: baseline-mutation rate wildtype (solid red), baseline-mutation rate resistant (solid black), hypermutant
wildtype (dashed red), and hypermutant resistant (dashed black). The inset plots show the frequencies of all
wildtype (hypermutant and baseline combined) cells (gray) and all resistant cells (light red). Intermediate
mutation rate increases (f = 60, 100, 150, 250) in this case result in the resistant mutant becoming dominant by
the time that resource saturation and hence a stationary-state distribution are reached, whereas lower and higher
mutation rate increases have a wildtype-dominated stationary-state distribution. Model parameters were set at
gr = 3.5× gwt with gwt = 0.34 h−1, xtot(t = 0) = 106, K = 108, Pwt→r = 0.01, xr(t = 0) = 0, xh(t = 0) = 5%
(all wildtype hypermutants), rµ = 1%, and Pdel = 0.9.
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